Leyden Labs raised $140 million in Series B funding led by Casdin Capital and GV.

Biotech Health services

Netherlands

United States

Japan

Investments

23 January 2022

Share:

Leyden Labs (company)

Netherlands

Biotech Health services

Total investments received (USD): 294.03m

Round value (USD): 140m

Round investors: Casdin Capital GV SoftBank Group Bluebird Ventures

Company: Leyden Labs

Industry: Biotech Health services

Related deals

Perpetual Next announced a €320 million round of funding.

Energy Manufacturing

Netherlands

Investments 12 June 2022

ImCheck Therapeutics raised €96m in Series C funding co-led by Earlybird and Andera Partners.

Biotech Health services Pharma

France

Germany

Sweden

Belgium

United States

Investments 08 June 2022

Backbase raised €120M in a growth equity round of funding backed by Motive Partners

Financial Services Software Services

Netherlands

United States

Investments 04 June 2022

Pyramid Analytics in a $120 million series E co-led by H.I.G. Growth Partners, Clal Insurance Enterprises Holdings and General Oriental Investments.

Competitive Intelligence Legal Services Software Services

Netherlands

United States

Israel

Luxembourg

Switzerland

Investments 06 May 2022

Mayht was acquired by Sonos in a $100 million all cash deal.

Hardware Manufacturing Music Industry Software Services

Netherlands

MA 10 April 2022